Argenx Advances Efgartigimod Into China With Zai Lab Pact

Selects Option Of $75m In Stock For Upfront

 
• By Kevin Grogan
  
Shanghai
200,000 people in China live with myasthenia gravis. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business